MedBright AI Announces New Commercial Product Demos for MedMatrix AI Platform
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) — MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) […]
Draganfly to Showcase Latest UAV Technology at Special Operations Forces Week 2024 – Booth #3701
Tampa, Florida, May 02, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
Regenx Granted Management Cease Trade Order by the ASC
EDMONTON, Alberta, May 01, 2024 (GLOBE NEWSWIRE) — Regenx Tech Corp., (the “Company” or “Regenx”) (CSE: RGX) (OTCQB: RGXTF) (FSE: […]
Draganfly Announces Closing of US$3.5 Million Registered Direct Offering
Saskatoon, SK., May 01, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
Aduro Clean Technologies présente ses résultats financiers pour le troisième trimestre 2024
LONDON, Ontario, 01 mai 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (CSE : ACT) (OTCQX : ACTHF) [...]
Aduro Clean Technologies gibt Finanzergebnisse für das dritte Quartal 2024 bekannt
LONDON, Ontario, May 01, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. („Aduro“ oder das „Unternehmen“) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), ein kanadisches [...]
Victory Square Technologies Reports 2023 Financial Results
A diverse portfolio of 25+ innovative companies from around the world (founders from: Ireland, Sri Lanka, Bulgaria, Australia, India, Brazil, […]
Goodness Growth Provides CREAM & Fire Updates
– Josh Rosen to shed Interim title and become Chief Executive Officer; Company provides other key personnel updates – – […]
Treatment.com AI Announces Contract Renewal with Leading US Medical School
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” […]
PharmaTher’s Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine
TORONTO, May 01, 2024 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty […]
